The correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic embolism was studied in 126 consecutive patients with idiopathic dilated cardiomyopathy who were examined from January 1980 to September 1987. A total of 1041 serial echocardiograms were obtained with 3-5 and 5 MHz transducers. The mean follow up period was 41-2 months. The survival rate was 88% at two years and 56% at five years. Echocardiography showed intracavitary thrombi in 14 (I 1 v1 %) patients; 13 were mural and 11 were localised at the apex of the left ventricle. Twelve patients (8-4%) had systemic emboli; this corresponded to an incidence ofnew embolic events of 1-4 for 100 patient-years. Patients with intracavitary thrombi or systemic emboli were treated with oral anticoagulants, as were nine in functional class IV of the New York Heart Association, for 61 patient-years. The cumulative observation period for the whole population study was 418 patient-years. None of the patients with intracavitary thrombosis had embolic complications and none of those with embolism had intracavitary thrombi. Rates of intracavitary thrombosis and systemic embolism in this series were low and there was no overlap between the two events. This may have been because the patients did not have severe dilated cardiomyopathy, because echocardiography did not detect all the thrombi, or because patients were treated with oral anticoagulants.
Although intracardiac thromboses have been identified by cross sectional echocardiography in a high percentage ofpatients with dilated cardiomyopathy,' the correlation of these findings with clinical evidence of systemic embolism is still controversial.2 Because this may be relevant to indications for anticoagulant treatment in these patients, we studied a series of patients with dilated cardiomyopathy by serial cross sectional echocardiography to see
Intracavitary thrombosis in dilated cardiomyopathy dilated cardiomyopathy were an enlarged cardiac left ventricular diastolic dimension (normalised for body surface area), decreased mitral valve opening, and fractional shortening of the left ventricle <25%. Normal values were derived from published data by Feigenbaum .' Angiographic criteria were the absence of critical obstructions ( > 50%) of the right coronary artery, anterior descending and circumflex branches of the left coronary artery and an ejection fraction of <0 45.
M mode and cross sectional echocardiography were performed at the initial evaluation in the study and every six months thereafter. When intracoronary thrombosis was identified or an embolic event occurred echocardiograms were performed within the next month and then every three months. A total of 1041 echocardiograms were performed. The follow up period lasted 1-92 months (mean 41-2). The survival rate was 88% at two years and 56% at five years. Echocardiograms were performed with a Smith Kline instrument (model 5000) and a 3-5 MHz transducer. When a left ventricular thrombus was detected the examination was repeated with a 5 MHz probe. Echoes were recorded on a Panasonic video recorder (model 8500). Echocardiographic studies were performed in the parasternal and apical views with the patient in the supine position or the 30@°45' left lateral position. Two chamber and four chamber views gave a better image of the left ventricle, particularly the apex. Left ventricle thrombosis was diagnosed when we saw abnormal intracavitary echoes that resembled a mass adjacent to the ventricular wall and clearly were distinguishable from papillary muscle, trabeculae, and endocardium. These were generally found near the cardiac apex, protruding into the cavity. They were fixed or occasionally mobile. The echoes were unlike those coming from the adjacent myocardium. 4 The echocardiographic studies were reviewed independently by two Intracardiac thrombosis was detected at the onset of the study in seven patients and during follow up in other seven. In 13 of these patients the intracardiac thrombosis was mural, while in the remaining patient it was pedunculated and mobile inside the left ventricular cavity. The most frequent site was the apex of the left ventricle (11/14 patients) ( fig 1) ; in one patient the thrombus was localised in the left atrial cavity; in one a small thrombus was attached to the inferior portion of the left side of the intraventricular septum; while in another it was at the level of mitral valve apparatus. In four patients the diagnosis ofintracardiac thrombosis by the 3 5 MHz probe was not confirmed by the use of the 5 MHz probe, which showed only the presence of muscular trabeculae or endocardial thickening of the apex.
Embolism occurred in 12 patients (8A4%): seven before they entered the study and five during follow up. The occurrence ofnew embolic events in patients not taking anticoagulants was 1-4 events for every 100 patient-years. Eleven of 12 patients had systemic embolic events (cerebral in eight, peripheral in two, renal in one) while one patient had a systemic (cerebral) and pulmonary embolism. None of the 14 patients with intracardiac thrombosis had embolism either before entry to the study or 3-5 new embolic events occurred every 100 patient-years in patients 29 not treated with anticoagulants," in comparison with 1-4 events for the same period in the present series. The difference in the population studies according to the severity of the disease may be responsible for these results. For instance survival rate was 88% in our study at two years and 56% at five years, while in the Mayo Clinic series it was respectively about 50 and 30%."
Only one of our patients had a protruding left ventricular thrombi; increased motility was reported to promote embolism in patients with ischaemic heart disease.21516 A mobile thrombus was reported in 27-58% of the patients in these studies. Gottdiener et al did not find similar results in patients with idiopathic dilated cardiomyopathy. They reported that the shape of the thrombus (flat or pedunculated) did not influence the occurrence of embolism.'
The pathophysiology of thrombus formation and embolisation are notably different in patients with "ischaemic cardiomyopathy"'7 and in those with idiopathic dilated cardiomyopathy.' The endocardial abnormalities that stimulate clot formation in acute infarction and chronic aneurysm (for example stasis of blood in the cardiac apex (fig 1) ) are different or absent in patients with idiopathic dilated cardiomyopathy.
An intracardiac thrombus disappeared during anticoagulant treatment in two of our patients (fig 2) . Treatment with oral anticoagulants, which were also given to five patients during follow up as soon as the embolic event occurred, might have led to the rapid resolution of the intracardiac thrombosis before the echocardiogram was performed,'8 thus further reducing any possible correlation ofthe two events in this subgroup.
Although atrial fibrillation has been claimed by some to be an important influence on We conclude that anticoagulant treatment may not be needed by every patient with dilated cardiomyopathy but should be given to patients with severe heart failure, previous embolism, and intracavitary thrombosis.
